baber/WOPTO huggingface dataset:
Patent PT-1562968-E (PT)
Title: Anti-il-6 antibodies, compositions, methods and uses
Inventor: GILES-KOMAR JILL
IPC: C07K16/24
Filed: 2002-10-26
Abstract: The present invention related to at least one novel chimeric, humanized or CDR-grafted anti-IL-6 antibodies derived from the murine CLB-8 antibody, including isolated nucleic acids that encode at least one such anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, methods of making and using thereof, including therapeutic compositions, methods and devices.
Patent PT-1574805-E (PT)
Title: Counting device
Inventor: ACARRETA RAUL DELGADO
IPC: F41A19/01
Filed: 2002-12-05
Abstract: Device (12) for counting shots fired by an automatic firearm (11), comprising a cartridge chamber containing a cartridge that can be expelled through an expulsion window, comprising a first emission means that emits a continuous electromagnetic signal in such a manner that it is interrupted by a casing expelled from the cartridge chamber and corresponding to the used cartridge. The shot-counting device (12) of the invention is capable of monitoring the number of casings expelled from a cartridge chamber of the firearm (11) via an expulsion window and showing, on a display screen, the corresponding number of shots left available in a magazine (13) fitted to the firearm (11). <IMAGE>
Patent PT-1423100-E (PT)
Title: Plaster comprising sertaconazole for the treatment of dysfunctions and disorders of nails
Inventor: RUDY SUSILO DR
IPC: A61K47/12
Filed: 2002-09-04
Abstract: The present invention relates to plasters for prophylaxis and/or treatment of a dysfunction or disorder of nails, especially onychomycosis, onychocryptosis, nail psoriasis, melanonychia striata, onychodystrophy, the use of said platers and methods for prophylaxis and/or treatment of a dysfunction or disorder of nails using said plasters. Said dysfunction or disorder of nails may be induced or caused by drugs, systemic diseases, chemical compounds, physical influences, fungal, yeast, or bacterial infection of the nails and/or the nail beds, or in the context of skin diseases. The platers show good therapeutically effects on said dysfunction or disorder of nails without the need of drilling a hole into the nail and/or daily scraping of the nail. Preferred embodiments of the plasters consist of an occlusive backing layer and a layer attached to said backing layer. The layer comes in close contact with the nail and optionally with the surrouding skin. The layer is made of a adhesive, a skin and/or nail permeation enhancer, a therapeutically effective amount of sertaconazole, and suitable additives, and/or further pharmaceutically active agents.
Patent PT-1501769-E (PT)
Inventor: LORIS AMATHIEU
IPC: C04B24/24
Filed: 2003-04-24
Abstract: Ettringite binder for dense mortar comprises calcium sulfates and a mineral compound of aluminates comprising soluble oxides of calcium (C) and aluminum (A) combined in one or more crystalline and/or amorphous phases. The molar ratio C/A of the mineral compound is 1.2-2.7. The total weight of the phases (C+A) is at least 30% of the total weight of the mineral compound. Preferred Features: The weight ratio of the mineral compound of calcium aluminates to calcium sulfate is 0.5-4, more preferably 1.5-3. The molar ratio of calcium sulfate to aluminum oxide (A) in the ettringite binder is 0.5-2, more preferably 0.6-1.8, and especially 0.8-1.7. The molar ratio C/A of the mineral compound of calcium aluminates is 1.3-2.5, more preferably 1.6-2. The ratio of water to solids, on mixing the ettringite binder with water, is less than 0.5. The mortar may not comprise Portland cement and/or hydraulic lime, or may comprise Portland cement and/or hydraulic lime in an amount less than 3.5 weight % with respect to the total weight of the dry mortar. The total amount of the phases (C+A) is at least 50% of the total weight of the mineral compound of calcium aluminates. Independent claims are given for: (a) a dry mortar containing (in weight % with respect to the total weight of the dry mortar): the invented ettringite binder 15-75; limestone or siliceous sand fillers 25-85; lime and/or Portland cement 0-3.5; dispersible polymer powder 0-8 and/or a solid-liquid polymer dispersion 0-20; and rheological and/or set-time control additives; (b) a dry mortar containing (in weight % with respect to the total weight of the dry mortar): the invented ettringite binder 20-50; limestone or siliceous sand fillers 50-80; lime and/or Portland cement 0-0.5; dispersible polymer powder 0-5 and/or a solid-liquid polymer dispersion 0-15; and rheological additives 0.1-0.5 and/or set-time control additives 0.1-0.5; (c) a wet mortar obtained by mixing the dry mortar with water in an amount such that the weight ratio of water to solids is less than 0.5. (d) Use of the mineral compound of aluminates in the formulation of an ettringite binder, and in the formulation of the dry and wet mortars.
Patent PT-1553058-E (PT)
Title: Method and apparatus for the biological treatment of a suspension in a bioreactor with integrated hydraulic sinking layer withdrawal
Inventor: BUECHNER THOMAS
IPC: C12M1/00
Filed: 2004-12-07
Abstract: Biological treatment of suspension in bioreactor comprises feeding horizontal jet(s) of fluid superimposing on the vertical flow in the bottom part of the bioreactor to establish a spiral flow to the central outlet area of the bioreactor. The bioreactor has central outlet area near the bottom. At least some of the suspension is routed through vertically aligned guide zone to circulate the suspension. Biological treatment of suspension in bioreactor (2) comprises feeding horizontal jet(s) of fluid superimposing on the vertical flow in the bottom part of the bioreactor to establish a spiral flow to the central outlet (17) area of the bioreactor. The bioreactor has central outlet area near the bottom. At least some of the suspension is routed through vertically aligned guide zone to circulate the suspension. The suspension is routed so that a vertical flow of portion(s) of the suspension is produced. The vertical flow of portion(s) of the suspension extends into the vicinity of the bottom of the bioreactor or proceeds from the vicinity of the bottom of the bioreactor. An independent claim is included for suspension biological treatment device comprising bioreactor for receiving the suspension, vertically aligned guide mechanisms in the interior of the bioreactor extending into the vicinity of the bottom region of the bioreactor for circulating the suspension, and nozzle (11, 13) for feeding fluid into the bioreactor in the vicinity of the bottom of the bioreactor.
Patent PT-1455255-E (PT)
Title: Regulator for low concentration corrosive and reactive gases
Inventor: JACKSIER TRACEY
IPC: G05D16/06
Filed: 2004-02-27
Abstract: A filter-less regulator is implemented for use in fluid flow systems that process low concentration reactive gases. The regulator includes an inlet, an outlet and a fluid flow path defined between the inlet and outlet by internal surfaces of the housing. The regulator further includes a pressure regulating section to reduce the pressure of a reactive gas flowing through the regulator between the housing inlet and the housing outlet. The internal surfaces of the housing are formed of a suitable material and the combined area of the internal surfaces is sufficiently sized to facilitate use of the regulator in the system without prior passivation for reactive gases at low concentrations (e.g., in the range of about 10 ppm or lower) while minimizing or substantially preventing significant loss of the reactive gas due to reaction and/or adsorption within the regulator. <IMAGE>
Patent PT-1523914-E (PT)
Title: A shower tray
Inventor: WILLIAM STIMPSON ROBERT
IPC: A47K3/40
Filed: 2004-08-13
Abstract: A shower tray has a trough 8 along one or more sides of the tray and means 81 for clamping flexible floor covering material 61 and/or a flexible edge of a ramp device in the trough(s). The clamping means may comprise one or more elongate clamping elements and means 64, 84 for fixing the clamping element(s) in the trough(s). <IMAGE>
Patent PT-1682331-E (PT)
Title: Method for the production of capsules with heat-shrinkable skirt
Inventor: GRANGER JACQUES
IPC: B29C48/10
Filed: 2004-11-08
Abstract: The method involves forming an extruded tube (21) made of thermoplastic material by a die (31) of diameter D0, thickness E0 and area S0. The tube is axially drawn in order to obtain an axially elongated tube (22) of an area S1, where the value of S0/S1 is between 2 and 10. The tube is radially expanded for forming a radially expanded tube (23). The tube (23) is cut into several portions (24). Independent claims are also included for the following: (a) a heat-shrinkable cap intended to cork a mouth of bottle (b) a heat-shrinkable crown cap intended to cork the mouth of bottle (c) a cover intended to cork the mouth of an effervescent wine bottle (d) a stick of corks or covers formed by stacking of the corks and covers.
Patent PT-1641095-E (PT)
Title: Inside corner for raceways
Inventor: EBERLE PATRICK
IPC: H02G3/06
Filed: 2005-07-05
Abstract: The corner piece used to fill the internal corner formed between two channel sections has a main section having a pair of arms [2,3] with a tip section less than 90 degrees. Pivot mounted on these are a pair of wing elements [11] that are spread by spring links [13] to fit closely in the corner between the channels.
Patent PT-1729732-E (PT)
Title: Anionic hydrogel matrices with ph dependent modified release as drug carriers
Inventor: GIAMMONA GAETANO
IPC: A61K47/34
Filed: 2005-02-16
Abstract: Compositions with pH-dependent modified release are described, consisting of hydrogel matrices containing one or more active ingredients, in which said matrices are suitable for releasing said active ingredients in a prolonged manner in given sites of the body.
Patent PT-1785165-E (PT)
Title: Anatomical and medical nasal respirator
Inventor: GUILDPHARMA S L
IPC: A61F5/08
Filed: 2005-04-26
Abstract: This inhaler (1) is composed of two parallel cylindrical tubes (1.1), a linking bridge (2) between said cylinders, and two threaded terminals (10, 11).  The inhaler is provided with three peripheral rings, one external one (5), one intermediate one (6) (located within each cylindrical tube) and one internal one (7), located in the terminal (10, 11), the section of which has a semicircular shape with a diameter of 2 mm. The planes of the external openings of the cylindrical tubes (1.1), form an angle of 130
.  The internal opening (4) of each cylinder is provided with a threaded terminal with two standard lengths of 5 mm and 9 mm, which a variable in other versions.  The average exterior diameter of the terminals is of 10 mm, although it can vary between 8 y 14 mm, at intervals of 2 mm.
Patent PT-1778791-E (PT)
Title: Colored oxygen scavenging polymers
Inventor: LIU ZHENGUO
IPC: C08L77/00
Filed: 2005-08-17
Abstract: The present invention relates to a melt blend of a base polymer, an oxidizable organic polymer, a transition metal salt catalyst and a colorant that does not completely deactivate the catalyzed oxidation. A preferred colorant, yields in an article made from the polymer melt blend a Catalyst Deactivation Factor (CDF) of less than about 0.25, preferably less than 0.15, more preferably less than 0.1, and most preferred less than 0.05. The present invention also comprises a colored monolayer article having the described CDF, such as a film, thermoformed tray, or blow molded container, that has active oxygen scavenging properties. The colorant, after melt blending a base polymer, an oxidizable organic polymer, a transition metal catalyst, does not increase the binding energy of the transition metal catalyst ion by more than 1 eV.
Patent PT-1779840-E (PT)
Title: Cosmetic compositions comprising a liquid ester, an acrylic thickening polymer, a cyclodextrin and an anionic surfactant, and use thereof
Inventor: MUELLER RAINER
IPC: A61Q5/02
Filed: 2006-09-29
Abstract: Cosmetic composition comprises an anionic surfactant, a liquid ester of 4-6 carbon carboxylic acid and 12-26 carbon alcohol, a cyclodextrin or its derivatives and an acrylic polymer thickener, in an aqueous medium. Independent claims are included for: (1) a process of cosmetic treatment of the keratinous matters, particularly hair, comprising applying the composition to the keratinous matter and optionally rinsing the treated matter with water; and (2) a method of improving the storage stability of the cosmetic composition.
Patent PT-1999109-E (PT)
Title: Styrylpyridine derivatives and their use for binding and imaging amyloid plaques
Inventor: KUNG HANK F
IPC: A61K51/04
Filed: 2007-03-26
Abstract: This invention relates to a method of imaging amyloid deposits and to styrylpyridine compounds, and methods of making radiolabeled styrylpyridine compounds useful in imaging amyloid deposits. This invention also relates to compounds, and methods of making compounds for inhibiting the aggregation of amyloid proteins to form amyloid deposits, and a method of delivering a therapeutic agent to amyloid deposits.
Patent PT-1988909-E (PT)
Title: Use of polyethylene glycol in inflammation related topical disorders or diseases and wound healing
Inventor: PLAS DAVE VAN DEN
IPC: A61K31/765
Filed: 2007-07-30
Abstract: The present invention relates to hydrogel compositions or aqueous solutions comprising one or more forms of Poly-ethylene Glycol, for use as medicaments, more particularly for topical application in the treatment of wounds, for the treatment of inflammatory skin disease and in particular for the prevention of scar formation and/or for enhancing the repair of damaged skin or mucosa.
Patent PT-2057165-E (PT)
Title: Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases
Inventor: SCHRAMM VERN L
IPC: A61K31/519
Filed: 2007-09-07
Abstract: The invention relates to compounds of the general formula (I) which are inhibitors of purine nucleoside phosphorylases (PNPs) and/or nucleoside hydrolases (NHs). The invention also relates to the use of these compounds in the treatment of diseases and infections including cancer, bacterial infections, protozoal infections, and T-cell mediated disease and to pharmaceutical compositions containing the compounds.
Patent PT-2218636-E (PT)
Title: Device for protecting ship seawater intakes from corrosion and fouling
Inventor: OETTEL RUEDIGER
IPC: B63B59/04
Filed: 2009-12-04
Abstract: The device has an anode ring (1) that is designed as a flange-like ring and fixed at a sea water inlet. The anode has half rings (2, 3) that are made of different materials such as copper and aluminum for releasing free ions. The half rings are partially isolated by a plastic coating. A receiving area at the sea water inlet is isolated by a casing (4). The anode ring has an internal area that is turned towards sea water and formed as a passage area (5) without isolation. The plastic coating consists of plastic such as polyurethane.
Patent PT-769967-E (PT)
Title: Conjugates comprising an antitumour agent and their use
Inventor: TROUET ANDRE
IPC: A61K47/48
Filed: 1995-08-21
Abstract: Prodrugs of formula W-Z-M (I) are new:. M = label or therapeutic agent having an active intracellular site (SA); W-Z is a ligand, comprising arm Z and end gp. W; the bond between Z and M inhibits intracellular penetration of (I) and/or inhibits expression of marker-M, and this bond is cleaved selectively by factors secreted by target cells such that M can then be expressed or can enter the cell; W ensures stability of (I) in serum and circulating blood.
Patent PT-828819-E (PT)
Inventor: OUTTRUP HELLE
IPC: A01N63/23
Filed: 1996-05-17
Abstract: This invention is directed to Bacillus mutants which produce a factor which potentiates the pesticidal activity of a Bacillus related pesticide, a chemical pesticide and/or a virus with pesticidal properties.
Patent PT-833903-E (PT)
Inventor: KAPIL SANJAY
IPC: C12N15/11
Filed: 1996-06-07
Abstract: New purified and isolated bovine coronavirus (BCV) types (II and III) are described which can be used to create new modified live vaccines for administration to cattle in order to confer immunity against virulent wild-type bovine coronavirus infection. Preferably, a multivalent modified live vaccine is provided for oral-nasal administration which includes the known Type I virus and the new Types II and III virus. Hygromycin B has also demonstrated to be effective for suppressing BCV replication and thus can be administered to cattle as a treatment for the chronic disease and to suppress shedding of BCV in cattle feces.
Patent PT-865410-E (PT)
Inventor: LYON MARIE-FRANCOISE
IPC: B32B7/04
Filed: 1996-11-22
Abstract: This invention consists of a disposable, absorbent article which absorbs animal perspiration. The article is characterized by the following features: an absorbent layer, and at least one reinforcing layer in order to insure article strength during use. Preferably, the absorbent layer is a flat layer having at least one superabsorbent material and either a non-woven fabric or at least one pad of fibers, and has an absorption capacity of at least 150 g of perspiration per m2 of the absorbent layer. Preferably, the at least one reinforcing layer is at least a pair of gas-permeable reinforcing layers respectively bound to each side of the absorbent layer, and the at least one reinforcing layer is made of a microperforated film or a non-woven fabric. Preferably, each layer of the article is liquid permeable.
Patent PT-907857-E (PT)
Inventor: ANDRE MICHEL
IPC: F16L33/02
Filed: 1997-07-01
Abstract: PCT No. PCT/FR97/01171 Sec. 371 Date Dec. 29, 1998 Sec. 102(e) Date Dec. 29, 1998 PCT Filed Jul. 1, 1997 PCT Pub. No. WO98/00665 PCT Pub. Date Jan. 8, 1998A clamping collar (10) constituted by a semi-rigid wire that is rolled up to form at least one turn (11) with a first end (12) thereof being provided with a hook (16) extending transversely to the plane of the turn and with a second end (14) thereof being folded back outwardly to form an extension (26) lying substantially in the plane of the turn. The extension (26) includes a fastening fold (28) forming a setback going towards the center of the turn, and it also includes a pre-fastening fold (32) situated between that end (24) of the extension (26) which is connected to the turn (11) and the fastening fold (28), said pre-fastening fold being analogous to the fastening fold.
Patent PT-866157-E (PT)
Inventor: HORTER HANSJURGEN
IPC: D03J1/00
Filed: 1998-03-05
Abstract: To change the configuration of a loom, to change the fabric weaving or replace the warp beam, a harness is brought to the loom to release or seal off the connections to a Jacquard, so that the loom mechanism can be withdrawn and replaced as a unit. Also claimed is a harness movement trolley (28) with holders to take and deliver the harness cables (2), comber board and the lowering mechanism. The trolley (28) also accommodates the warp beam (18), warp monitor (22) and/or reed (23).
Patent PT-964874-E (PT)
Title: A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof
Inventor: BRAM RICHARD J
IPC: C12N5/10
Filed: 1998-03-03
Abstract: There is provided an isolated polypeptide comprising a fragment of a Transmembrane Activator and CAML-Interactor (TACI) protein comprising an N-terminal fragment of the TACI protein comprising the ligand-binding domain.
Patent PT-974335-E (PT)
Inventor: DUBIEF CLAUDE
IPC: C08L83/08
Filed: 1999-07-07
Abstract: Cosmetic one component washing agent and conditioner formulations contain anionic detergent, amphoteric detergent and an aminated silicone. Cosmetic detergent and conditioning compositions comprise, in an appropriate aqueous medium, (A) a washing base comprising at least one anionic surfactant and at least one amphoteric surfactant, and (B) a conditioner system comprising at least an aminated silicone with an amine index of greater than or equal to 0.4 meq/g, especially 0.5-5 meq/g, selected from (a) a cationic silicone polymer of formula (I); R'aG3-a-Si(OSiG2)n-(OSiGbR'2-b)m-O-SiG3-a-R'a (I) G = H, phenyl, OH or 1-8C alkyl such as Me; a = 0 or a whole number 1-3, especially 0; b = 0 or 1, especially 1; m and n = numbers such that (n+m) = 1-2000 (50-150), n = 0-1999 (49-149) and m = 1-2000 (1-10); R' = a monovalent radical of formula -CqH2qL in which q = 2-8 and L = an aminated group selected from -N(R)-CH2-CH2-N(R)2 -N(R)2 -N<+)<R)3A<-> -N<+>H(R)2A<-> -N<+>H2(R)A<-> -N(R)-CH2-CH2-N<+>RH2A<-> in which R (same or different) = H, phenyl, benzyl, or a saturated monovalent hydrocarbon radical such as a 1-20 C alkyl radical and especially Me; A<-> = an organic or inorganic anion (b) a cationic silicone polymer of formula (IV); R5 = 1-18 C monovalent hydrocarbon radical, especially 1-18 C alkyl or 2-18 C alkenyl, particularly Me; R6 = a divalent hydrocarbon radical, especially 1-18 (1-8 C) alkylene or 1-18 C (1-8 C) alkyleneoxy radical; Q<-> = organic or inorganic anion; r = a statistical average value of 2-20,especially 2-8; s = a statistical average value of 20-200, especially 20-50 the weight ratio amphoteric surfactant/anionic surfactant being greater than or equal to 0.2, preferably 0.3-3.
Patent PT-1083168-E (PT)
Inventor: SATO FUMIE
IPC: C07C405/00
Filed: 1999-05-25
Abstract: A sleep-inducing preparation which comprises as an effective ingredient a prostaglandin derivative represented by the formula: <CHEM>  wherein X is a halogen atom, Y is a group represented by (CH2)m, a cis-vinylene group or a phenylene group, Z is an ethylene group, a trans-vinylene group, OCH2 or S(O)nCH2, R<1> is a C3-10 cycloalkyl group, a C3-10 cycloalkyl group substituted with C1-4 alkyl group(s), a C4-13 cycloalkylalkyl group, a C5-10 alkyl group, a C5-10 alkenyl group, a C5-10 alkynyl group or a bridged cyclic hydrocarbon group, R<2> is a hydrogen atom, a C1-10 alkyl group or a C3-10 cycloalkyl group, m is an integer of 1 to 3, and n is 0, 1 or 2, a pharmaceutically acceptable salt thereof or a hydrate thereof. <IMAGE>
Patent PT-1092027-E (PT)
Title: Therapeutic and diagnostic domain 1 beta 2 gp1 polypeptides and methods of using same
Inventor: JONES DAVID S
IPC: A61K47/48
Filed: 1999-06-09
Abstract: The present invention provides domain 1 beta2GPI polypeptides, polynucleotides encoding these polypeptides, mimetics of these polypeptides, and methods using domain 1 beta2GPI polypeptides and mimetics. Domain 1 of beta2GPI has been shown to bind to anti-cardiolipin (beta2GPI-dependent antiphospholipid) antibodies, which are associated with several pathologies, such as thrombosis and fetal loss. The domain 1 beta2GPI polypeptides may be used to detect beta2GPI-dependent antiphospholipid antibodies in a sample. The invention further provides methods of inducing tolerance using these domain 1 beta2GPI polypeptides.
Patent PT-1141066-E (PT)
Inventor: PROBST JOACHIM
IPC: C08G18/28
Filed: 1999-12-06
Abstract: This invention relates to aqueous two-component polyurethane systems, to a process for producing them, and to their use for the production of coatings having an enhanced impact strength and good resistance to solvents.
Patent IE-780094-L (IE)
Title: Amino acid derivatives
IPC: A61K31/22
Filed: 1978-01-16
Abstract: New substituted acyl derivatives of amino acids which have the general formula <IMAGE> are useful as angiotensin converting enzyme inhibitors.
[US4113715A]
Patent IE-40568-L (IE)
Title: Run-flat tyre with sidewall insert
IPC: B60C17/08
Filed: 1975-01-21
Abstract: This disclosure relates to a pneumatic tire that is designed to be run-flat for a certain distance without destroying the remaining life of the tire as a result of injuries to the tire during its run-flat operation. The disclosure further relates to a combination of this tire with a special rim and internal lubricating means within the air chamber defined by the rim and tire. This combination further enhances the non-destructive run-flat characteristics of the tire.